塩野義製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/12/08 | 7,046 | 7,058 | 6,966 | 7,028 | -36 | -0.5% | 1,606,200 |
| 2023/12/07 | 7,089 | 7,126 | 7,051 | 7,064 | -16 | -0.2% | 1,117,600 |
| 2023/12/06 | 6,988 | 7,086 | 6,974 | 7,080 | +119 | +1.7% | 824,100 |
| 2023/12/05 | 6,974 | 6,993 | 6,912 | 6,961 | ±0 | ±0% | 841,700 |
| 2023/12/04 | 6,964 | 6,979 | 6,910 | 6,961 | -79 | -1.1% | 603,800 |
| 2023/12/01 | 7,030 | 7,062 | 7,015 | 7,040 | +62 | +0.9% | 837,900 |
| 2023/11/30 | 6,884 | 6,986 | 6,846 | 6,978 | +108 | +1.6% | 2,703,800 |
| 2023/11/29 | 6,888 | 6,909 | 6,814 | 6,870 | -85 | -1.2% | 863,000 |
| 2023/11/28 | 6,961 | 6,982 | 6,928 | 6,955 | -15 | -0.2% | 774,500 |
| 2023/11/27 | 7,053 | 7,096 | 6,970 | 6,970 | -80 | -1.1% | 691,200 |
| 2023/11/24 | 7,035 | 7,106 | 7,033 | 7,050 | +82 | +1.2% | 899,100 |
| 2023/11/22 | 6,945 | 7,027 | 6,934 | 6,968 | -7 | -0.1% | 819,000 |
| 2023/11/21 | 7,085 | 7,085 | 6,925 | 6,975 | -122 | -1.7% | 1,176,500 |
| 2023/11/20 | 7,121 | 7,171 | 7,092 | 7,097 | -5 | -0.1% | 979,800 |
| 2023/11/17 | 7,079 | 7,122 | 7,061 | 7,102 | +32 | +0.5% | 981,700 |
| 2023/11/16 | 7,045 | 7,091 | 7,041 | 7,070 | -2 | ±0% | 893,000 |
| 2023/11/15 | 7,065 | 7,122 | 7,011 | 7,072 | +16 | +0.2% | 1,226,400 |
| 2023/11/14 | 7,090 | 7,105 | 7,003 | 7,056 | -26 | -0.4% | 867,400 |
| 2023/11/13 | 7,140 | 7,182 | 7,073 | 7,082 | +1 | ±0% | 1,224,500 |
| 2023/11/10 | 7,077 | 7,092 | 7,043 | 7,081 | +2 | ±0% | 898,300 |
| 2023/11/09 | 7,065 | 7,081 | 7,016 | 7,079 | +14 | +0.2% | 860,400 |
| 2023/11/08 | 7,100 | 7,109 | 7,042 | 7,065 | -5 | -0.1% | 1,176,300 |
| 2023/11/07 | 7,122 | 7,181 | 7,065 | 7,070 | -52 | -0.7% | 1,166,300 |
| 2023/11/06 | 7,179 | 7,189 | 7,074 | 7,122 | +19 | +0.3% | 1,328,700 |
| 2023/11/02 | 7,154 | 7,179 | 7,070 | 7,103 | -49 | -0.7% | 1,371,100 |
| 2023/11/01 | 7,050 | 7,154 | 6,966 | 7,152 | +165 | +2.4% | 2,149,500 |
| 2023/10/31 | 6,907 | 7,064 | 6,865 | 6,987 | +126 | +1.8% | 2,040,900 |
| 2023/10/30 | 6,857 | 6,909 | 6,842 | 6,861 | -69 | -1% | 1,440,900 |
| 2023/10/27 | 6,804 | 6,930 | 6,784 | 6,930 | +93 | +1.4% | 1,060,700 |
| 2023/10/26 | 6,883 | 6,897 | 6,812 | 6,837 | -42 | -0.6% | 1,142,500 |
| 2023/10/25 | 6,892 | 6,927 | 6,839 | 6,879 | +22 | +0.3% | 1,165,600 |
| 2023/10/24 | 6,822 | 6,878 | 6,752 | 6,857 | -65 | -0.9% | 1,765,300 |
| 2023/10/23 | 6,971 | 6,982 | 6,912 | 6,922 | -71 | -1% | 1,030,000 |
| 2023/10/20 | 6,987 | 7,039 | 6,970 | 6,993 | -14 | -0.2% | 1,492,200 |
| 2023/10/19 | 7,007 | 7,099 | 6,988 | 7,007 | -58 | -0.8% | 1,903,200 |
| 2023/10/18 | 6,946 | 7,085 | 6,930 | 7,065 | +211 | +3.1% | 2,832,500 |
| 2023/10/17 | 6,880 | 6,893 | 6,777 | 6,854 | +30 | +0.4% | 1,541,300 |
| 2023/10/16 | 6,796 | 6,828 | 6,764 | 6,824 | +28 | +0.4% | 1,363,400 |
| 2023/10/13 | 6,879 | 6,922 | 6,770 | 6,796 | -61 | -0.9% | 1,918,600 |
| 2023/10/12 | 6,700 | 6,881 | 6,700 | 6,857 | +190 | +2.8% | 2,323,900 |
| 2023/10/11 | 6,592 | 6,692 | 6,575 | 6,667 | +37 | +0.6% | 1,087,300 |
| 2023/10/10 | 6,550 | 6,659 | 6,531 | 6,630 | +117 | +1.8% | 1,473,400 |
| 2023/10/06 | 6,453 | 6,531 | 6,438 | 6,513 | +60 | +0.9% | 858,900 |
| 2023/10/05 | 6,386 | 6,453 | 6,297 | 6,453 | +77 | +1.2% | 1,124,900 |
| 2023/10/04 | 6,439 | 6,457 | 6,367 | 6,376 | -146 | -2.2% | 1,040,700 |
| 2023/10/03 | 6,635 | 6,635 | 6,477 | 6,522 | -69 | -1% | 1,225,100 |
| 2023/10/02 | 6,674 | 6,733 | 6,591 | 6,591 | -95 | -1.4% | 1,037,400 |
| 2023/09/29 | 6,677 | 6,714 | 6,638 | 6,686 | -3 | ±0% | 1,996,500 |
| 2023/09/28 | 6,646 | 6,726 | 6,631 | 6,689 | -63 | -0.9% | 1,242,300 |
| 2023/09/27 | 6,672 | 6,752 | 6,628 | 6,752 | +88 | +1.3% | 1,281,000 |
101～
150
件表示中 / 3452件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 塩野義 | 748,900円 | +5.5% | -12.6% | 2.14% | 13.75倍 | 1.76倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| 大塚ＨＤ | 658,600円 | +6.0% | +131.3% | 1.82% | 14.30倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 152,700円 | +2.9% | +72.2% | 4.85% | 91.27倍 | 1.72倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| エーザイ | 679,300円 | -0.5% | +27.7% | 2.36% | 46.98倍 | 2.26倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 協和キリン | 266,900円 | +7.0% | -12.6% | 2.17% | 22.58倍 | 1.70倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム
